Treatment of Lymph Node-Negative, Early-Stage HER2-Positive Breast Cancer
- PMID: 26644534
- DOI: 10.1200/JCO.2015.63.8411
Treatment of Lymph Node-Negative, Early-Stage HER2-Positive Breast Cancer
Comment in
-
Reply to A. Oguz et al.J Clin Oncol. 2016 Feb 20;34(6):640-1. doi: 10.1200/JCO.2015.65.1034. Epub 2015 Dec 7. J Clin Oncol. 2016. PMID: 26644531 No abstract available.
Comment on
-
Efficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastuzumab Trials.J Clin Oncol. 2015 Aug 20;33(24):2600-8. doi: 10.1200/JCO.2015.60.8620. Epub 2015 Jun 22. J Clin Oncol. 2015. PMID: 26101239 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
